Company Overview
Company Name
Gilead Sciences
Address
United States
Website
cymabay.comApprox. Annual Revenue
$0.5M
Employees
3
Established
2013
About Gilead Sciences
Gilead Sciences is a biopharma company headquartered in the United States with approximately 11 employees. The company focuses on developing innovative treatments in areas such as HIV, liver disease, cancer, and inflammation, with a strong emphasis on research, diversity, and global health initiatives.
More Companies in California
Browse all companies in California →
'%20fill='%23CE1312'%3e%3cpath%20d='M219.044,391.269916%20L219.0425,377.687742%20L232.0115,384.502244%20L219.044,391.269916%20Z%20M247.52,375.334163%20C247.52,375.334163%20247.0505,372.003199%20245.612,370.536366%20C243.7865,368.610299%20241.7405,368.601235%20240.803,368.489448%20C234.086,368%20224.0105,368%20224.0105,368%20L223.9895,368%20C223.9895,368%20213.914,368%20207.197,368.489448%20C206.258,368.601235%20204.2135,368.610299%20202.3865,370.536366%20C200.948,372.003199%20200.48,375.334163%20200.48,375.334163%20C200.48,375.334163%20200,379.246723%20200,383.157773%20L200,386.82561%20C200,390.73817%20200.48,394.64922%20200.48,394.64922%20C200.48,394.64922%20200.948,397.980184%20202.3865,399.447016%20C204.2135,401.373084%20206.612,401.312658%20207.68,401.513574%20C211.52,401.885191%20224,402%20224,402%20C224,402%20234.086,401.984894%20240.803,401.495446%20C241.7405,401.382148%20243.7865,401.373084%20245.612,399.447016%20C247.0505,397.980184%20247.52,394.64922%20247.52,394.64922%20C247.52,394.64922%20248,390.73817%20248,386.82561%20L248,383.157773%20C248,379.246723%20247.52,375.334163%20247.52,375.334163%20L247.52,375.334163%20Z'%20id='Youtube'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
%20--%3e%3csvg%20version='1.1'%20id='st_x5F_cc_x5F_app_x5F_RGB.svg'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20x='0px'%20y='0px'%20viewBox='0%200%20240.0004%20234.0004'%20style='enable-background:new%200%200%20240.0004%20234.0004;'%20xml:space='preserve'%3e%3cstyle%20type='text/css'%3e%20.st0{fill:url(%23SVGID_1_);}%20.st1{fill:%23FFFFFF;}%20%3c/style%3e%3clinearGradient%20id='SVGID_1_'%20gradientUnits='userSpaceOnUse'%20x1='119.9997'%20y1='234.0002'%20x2='119.9997'%20y2='0.0002'%3e%3cstop%20offset='0'%20style='stop-color:%23201F21'/%3e%3cstop%20offset='1'%20style='stop-color:%23313131'/%3e%3c/linearGradient%3e%3crect%20x='-0.0003'%20y='0.0002'%20class='st0'%20width='240'%20height='234'/%3e%3cg%3e%3cpath%20class='st1'%20d='M132.24969,97.95853c-5.60328,18.77988-10.28088,36.91208-15.88416,54.63138%20c-3.18081,9.99579-6.66385,19.53729-11.05544,25.59485c-4.84678,6.81497-13.93402,13.32771-24.83743,13.32771%20c-7.72443,0-15.29683-3.63509-15.29683-11.66174c0-4.99789,5.14901-9.69264,9.23837-9.69264%20c2.42339,0,3.63508,1.36282,4.24046,2.42339c3.7862,6.81497,7.42128,10.75229,9.08724,10.75229s3.02878-2.27135,5.7544-12.1151%20l19.82331-73.26013H99.08337c-1.06058-3.18081,0.45427-7.11812,2.27135-7.87554h14.23625%20c2.72562-8.7841,5.92356-17.60862,10.46719-25.63529c6.81497-12.26713,17.7193-21.95976,32.71205-21.95976%20c11.3586,0,16.05333,5.45216,16.05333,12.41917c-0.15111,7.42036-6.66293,11.20656-9.69263,11.20656%20c-2.42247,0-3.63416-1.81709-4.39159-4.39159c-2.57451-9.69263-5.90643-12.57029-7.87555-12.57029%20c-1.9682,0-4.99789,3.63416-8.3289,11.20656c-4.3925,9.54151-7.28729,19.72977-10.01291,29.72464h17.26501%20c1.05966,2.12023,0.15112,6.66385-2.42339,7.87554H132.24969z'/%3e%3c/g%3e%3c/svg%3e)
